$PLAO
Patria Latin American Opportunity Acquisition Corp. Stock $plao

$plao Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000121390024028702 Filed on April 01, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$233.3K	$1.162M	$901.7K
YoY Change	34.73%	28.85%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$233.3K	$1.162M	$901.7K
YoY Change	34.73%	28.85%	1708.16%
Operating Profit		-$1.162M	-$901.7K
YoY Change		28.85%
Interest Expense	$3.286M	$11.67M	$10.47M
YoY Change	-24.45%	11.41%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$662.2K
YoY Change		-100.0%
Pretax Income	$3.125M	$10.58M	$9.256M
YoY Change	-25.16%	14.28%	-18660.76%
Income Tax
% Of Pretax Income
Net Earnings	$3.125M	$10.58M	$9.256M
YoY Change	-25.16%	14.28%	-18660.75%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.14	$0.42	$0.38
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$187.4M	$187.4M	$241.0M
YoY Change	-22.25%	-22.25%	54777113.64%
Cash & Equivalents	$47.05K
Short-Term Investments	$187.4M	$187.4M	$240.3M
Other Short-Term Assets	$50.97K	$50.97K	$307.8K
YoY Change	-83.44%	-83.44%	-51.82%
Inventory
Prepaid Expenses	$50.97K
Receivables
Other Receivables
Total Short-Term Assets	$187.5M	$187.5M	$241.3M
YoY Change	-22.32%	-22.32%	37656.39%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$187.5M	$187.5M	$241.3M
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$187.5M	$187.5M	$241.3M
YoY Change	-22.32%	-22.32%	37656.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$241.4K	$241.4K
YoY Change
Accrued Expenses	$74.76K	$74.76K	$68.63K
YoY Change	8.94%	8.93%	-69.7%
Deferred Revenue
YoY Change
Short-Term Debt	$2.100M	$2.100M	$3.140K
YoY Change	66778.98%	66778.98%	-99.28%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.221M	$7.221M	$10.46M
YoY Change	-30.98%	-30.98%	1475.47%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.221M	$7.221M	$10.46M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$7.221M	$7.221M	$10.46M
YoY Change	-30.98%	-30.98%	1475.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.124M
YoY Change	-24.59%
Common Stock	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$180.2M	$180.2M	$230.9M
YoY Change
Total Liabilities & Shareholders Equity	$187.5M	$187.5M	$241.3M
YoY Change	-22.32%	-22.32%	37656.39%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	$3.125M	$10.58M	$9.256M
YoY Change	-25.16%	14.28%	-18660.75%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$135.2K	-$657.6K	-$1.156M
YoY Change	36.83%	-43.13%	-262884.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$900.0K	$63.06M	-$236.9M
YoY Change		-126.62%
Cash From Investing Activities	-$900.0K	$63.06M	-$236.9M
YoY Change		-126.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$65.16M	$230.0M
YoY Change		-128.33%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	900.0K	-63.07M	$238.8M
YoY Change		-126.41%
NET CHANGE
Cash From Operating Activities	-135.2K	-657.6K	-$1.156M
Cash From Investing Activities	-900.0K	63.06M	-$236.9M
Cash From Financing Activities	900.0K	-63.07M	$238.8M
Net Change In Cash	-135.2K	-660.7K	$707.3K
YoY Change	36.83%	-193.41%	160652.05%
FREE CASH FLOW
Cash From Operating Activities	-$135.2K	-$657.6K	-$1.156M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41321
CY2023	dei	Entity Registrant Name EntityRegistrantName	PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	60 Nexus Way
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	4th Floor
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Camana Bay, PO Box 757
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Grand Cayman
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	KY1-9006
CY2023	dei	City Area Code CityAreaCode	1 345
CY2023	dei	Local Phone Number LocalPhoneNumber	640 4903
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	243
CY2023	dei	Auditor Name AuditorName	BDO USA, P.C
CY2023	dei	Auditor Location AuditorLocation	New York, NY
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47046	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	707749	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	50967	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	307756	usd
CY2023Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	187355645	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	240311986	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	187453658	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	241327491	usd
CY2023Q4	us-gaap	Assets Assets	187453658	usd
CY2022Q4	us-gaap	Assets Assets	241327491	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	241365	usd
CY2023Q4	plao	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	4025000	usd
CY2022Q4	plao	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	8050000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	780000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2340000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	74757	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	68627	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7221122	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10461771	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7221122	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10461771	usd
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	16880481	shares
CY2022Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	23000000	shares
CY2023Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	11.1
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.45
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	187355645	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	240311986	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7123684	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9446841	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-7123109	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9446266	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	187453658	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	241327491	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1161843	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	901733	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1161843	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-901733	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1560000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7060500	usd
CY2023	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	10107406	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	3411986	usd
CY2022	plao	Transaction Costs Allocation To Derivative Warrant Liabilities TransactionCostsAllocationToDerivativeWarrantLiabilities	314508	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	72651	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	10578214	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9256245	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9446266	usd
CY2023	plao	Stock Issued During Period Value Deferred Underwriting Fees Waiver StockIssuedDuringPeriodValueDeferredUnderwritingFeesWaiver	3952349	usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	12207406	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	10578214	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-7123109	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-24868	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	9251000	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	27928643	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9256245	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-9446266	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	10578214	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9256245	usd
CY2023	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	10107406	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	3411986	usd
CY2022	plao	Transaction Costs Allocated To Derivative Warrant Liabilities TransactionCostsAllocatedToDerivativeWarrantLiabilities	314508	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1560000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7060500	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	72651	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-256789	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	307756	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	241365	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6130	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	53239	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-657559	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1156250	usd
CY2022	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments	236900000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	65163585	usd
CY2023	plao	Proceeds From Redemption Of Us Government Treasury Obligations ProceedsFromRedemptionOfUSGovernmentTreasuryObligations	793469000	usd
CY2022	plao	Proceeds From Redemption Of Us Government Treasury Obligations ProceedsFromRedemptionOfUSGovernmentTreasuryObligations	715209000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	795568838	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	715209000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	63063747	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-236900000	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2100000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3144	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	437507	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	147190	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	230000000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	65163747	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	14500000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5151744	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-63066891	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	238763559	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-660703	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	707309	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	707749	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	440	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47046	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	707749	usd
CY2022	plao	Initial Shares Subject To Possible Redemption InitialSharesSubjectToPossibleRedemption	212383343	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	24516657	usd
CY2023	plao	Accretion Of Shares To Redemption Value AccretionOfSharesToRedemptionValue	12207406	usd
CY2022	plao	Accretion Of Shares To Redemption Value AccretionOfSharesToRedemptionValue	3411986	usd
CY2022	plao	Offering Costs Included In Accrued Expenses OfferingCostsIncludedInAccruedExpenses	211141	usd
CY2022	plao	Offering Costs Paid Prepaid Legal Expense Funded By Sponsor OfferingCostsPaidPrepaidLegalExpenseFundedBySponsor	150334	usd
CY2022	plao	Deferred Underwriting Fees Payable DeferredUnderwritingFeesPayable	8050000	usd
CY2023	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	4025000	usd
CY2022Q1	us-gaap	Share Price SharePrice	10
CY2023	plao	Transaction Costs TransactionCosts	13779665	usd
CY2023	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	8050000	usd
CY2023	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	4600000	usd
CY2023	plao	Other Offering Costs OtherOfferingCosts	1129665	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	314508	usd
CY2023	plao	Temporary Equity Charges TemporaryEquityCharges	13456157	usd
CY2023Q2	us-gaap	Assets Held In Trust AssetsHeldInTrust	180000000	usd
CY2023Q2	plao	Trust Account Withdrawal Tax Payment TrustAccountWithdrawalTaxPayment	300000	usd
CY2023Q4	us-gaap	Deposit Derivative Contract DepositDerivativeContract	2100000	usd
CY2023	plao	Fair Market Value Rate FairMarketValueRate	0.80	pure
CY2023	plao	Aggregate Public Share Percentage AggregatePublicSharePercentage	0.15	pure
CY2023Q4	plao	Public Shares Redeem Percentage PublicSharesRedeemPercentage	1	pure
CY2023	plao	Interest To Pay Dissolution Expense InterestToPayDissolutionExpense	100000	usd
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.3
CY2023Q4	plao	Working Capital Amount WorkingCapitalAmount	-2318109	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47046	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The preparation of these financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47046	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	707749	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	10578214	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	9256245	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable	-8255057	usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable	-27928643	usd
CY2023	plao	Net Income Loss Including Accretion Of Temporary Equity In Excess Of Fair Value NetIncomeLossIncludingAccretionOfTemporaryEquityInExcessOfFairValue	2323157	usd
CY2022	plao	Net Income Loss Including Accretion Of Temporary Equity In Excess Of Fair Value NetIncomeLossIncludingAccretionOfTemporaryEquityInExcessOfFairValue	-18672398	usd
CY2023Q4	us-gaap	Share Price SharePrice	10
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	12207406	usd
CY2023Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	65163747	usd
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	16880481	shares
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b><i>Concentration of Credit Risk</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p>
CY2023	us-gaap	Derivatives Methods Of Accounting Nonhedging Derivatives DerivativesMethodsOfAccountingNonhedgingDerivatives	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif"><b><i>Derivative Financial Instruments</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the issuance date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3000000	shares
CY2023Q2	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	22630481	shares
CY2023	plao	Granted Shares GrantedShares	90000	shares
CY2022Q1	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	662245	usd
CY2022Q1	plao	Stock Issued During Period Per Shares StockIssuedDuringPeriodPerShares	7.36
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	662245	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	662245	usd
CY2022Q1	plao	Number Of Shares Subject To Forfeiture NumberOfSharesSubjectToForfeiture	750000	shares
CY2021Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	250000	usd
CY2021Q4	plao	Promissory Note PromissoryNote	437508	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	70000	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	95484	usd
CY2023	plao	Working Capital Loans WorkingCapitalLoans	2000000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1560000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7060500	usd
CY2023	plao	Underwriting Discount Per Share UnderwritingDiscountPerShare	0.2
CY2023	plao	Underwriter Cash Discount UnderwriterCashDiscount	4600000	shares
CY2023Q4	plao	Deferred Underwriting Percentage DeferredUnderwritingPercentage	0.50	pure
CY2023	plao	Warrant Expiration Term WarrantExpirationTerm	P5Y
CY2023	us-gaap	Business Combination Control Obtained Description BusinessCombinationControlObtainedDescription	The Warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of an Initial Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the Initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A Ordinary Share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Initial Business Combination on the date of the consummation of the Initial Business Combination (net of redemptions) and (z) the volume weighted average trading price of Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the Initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the Warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $10.00” and “Redemption of Warrants when the price per Class A Ordinary Share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	187355645	usd
CY2023Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	187355645	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	780000	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	240311986	usd
CY2022Q4	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	240311986	usd
CY2022Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	2340000	usd
CY2022Q1	plao	Addition Liabilities AdditionLiabilities	9400500	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7060500	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2340000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1560000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	780000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-7060500	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2340000	usd
CY2023	plao	Transaction Costs Allocation To Derivative Warrant Liabilities TransactionCostsAllocationToDerivativeWarrantLiabilities		usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022	plao	Stock Issued During Period Value Underwriters Fees StockIssuedDuringPeriodValueUnderwritersFees		usd
CY2022	plao	Stock Issued During Period Value Deferred Underwriting Fees StockIssuedDuringPeriodValueDeferredUnderwritingFees		usd
CY2022	us-gaap	Warrant Down Round Feature Increase Decrease In Equity Amount1 WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount1		usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023	plao	Transaction Costs Allocated To Derivative Warrant Liabilities TransactionCostsAllocatedToDerivativeWarrantLiabilities		usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable		usd
CY2023	us-gaap	Payments To Acquire Trust Preferred Investments PaymentsToAcquireTrustPreferredInvestments		usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023	plao	Initial Shares Subject To Possible Redemption InitialSharesSubjectToPossibleRedemption		usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2023	plao	Offering Costs Included In Accrued Expenses OfferingCostsIncludedInAccruedExpenses		usd
CY2023	plao	Offering Costs Paid Prepaid Legal Expense Funded By Sponsor OfferingCostsPaidPrepaidLegalExpenseFundedBySponsor		usd
CY2023	plao	Deferred Underwriting Fees Payable DeferredUnderwritingFeesPayable		usd
CY2022	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice		usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001849737
CY2023Q2	dei	Entity Public Float EntityPublicFloat	0	usd

Files In Submission

Name	View Source	Status
0001213900-24-028702-index-headers.html	Edgar Link	pending
0001213900-24-028702-index.html	Edgar Link	pending
0001213900-24-028702.txt	Edgar Link	pending
0001213900-24-028702-xbrl.zip	Edgar Link	pending
ea0202545-10k_patria.htm	Edgar Link	pending
ea020254501ex31-1_patria.htm	Edgar Link	pending
ea020254501ex31-2_patria.htm	Edgar Link	pending
ea020254501ex32-1_patria.htm	Edgar Link	pending
ea020254501ex32-2_patria.htm	Edgar Link	pending
ea020254501ex4-1_patria.htm	Edgar Link	pending
ea020254501ex97_patria.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
plao-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
plao-20231231_cal.xml	Edgar Link	unprocessable
plao-20231231_def.xml	Edgar Link	unprocessable
plao-20231231_lab.xml	Edgar Link	unprocessable
plao-20231231_pre.xml	Edgar Link	unprocessable
ea0202545-10k_patria_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLAO
Patria Latin American Opportunity Acquisition Corp. Stock $plao

2023 Q4 Form 10-K Financial Statement

#000121390024028702 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLAO Patria Latin American Opportunity Acquisition Corp. Stock $plao

2023 Q4 Form 10-K Financial Statement

#000121390024028702 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLAO
Patria Latin American Opportunity Acquisition Corp. Stock $plao